baber/WOPTO huggingface dataset:
Patent NO-904368-D0 (NO)
Inventor: RHIND STEPHEN KEITH
IPC: A61K47/48
Filed: 1990-10-09
Abstract: Cross-linked labelled antibody conjugates are described which have at least one non-disulphide interchain bridge. The bridge may be the residue of a homo- or hereofunctional cross-linking reagent, and is located away from the antigen binding domains of the antibody. The antibody conjugates have an enhanced binding capacity and in vivo have good blood clearance and, in the presence of a tumour high tumour: blood and tumour: bone ratios. The conjugates are of use in the diagnosis and therapy of e.g. tumours and may be prepared by reaction of a cross-linking reagent with an antibody.
Patent NO-904957-D0 (NO)
Inventor: NICHT ERKANNT
IPC: F16H61/28
Filed: 1990-11-15
Abstract: PCT No. PCT/NO91/00142 Sec. 371 Date May 13, 1993 Sec. 102(e) Date May 13, 1993 PCT Filed Nov. 14, 1991 PCT Pub. No. WO92/08914 PCT Pub. Date May 29, 1992.A gear shift device for gear boxes for vehicles, comprising at least one pair of mutually connected, double-acting hydraulic cylinders (1,2), where the pair consists of a master cylinder (1) and a slave cylinder (21). The master cylinder can be operated via a gear lever and the slave cylinder moves a mechanism which is connected to gear selector carriers in the gearbox. According to the invention each end section of the master cylinder's (1) piston (4) has an outer (54 or 55) and an inner (56 or 57) piston sealing ring which are arranged at intervals, calculated in the piston's longitudinal direction, and in these end sections there is provided a drilling (52 or 53) whose first end leads into the piston surface between the respective end sections outer and inner sealing rings (54, 56 and 55, 57 respectively), and whose second ends leads into the adjacent end face of the piston (4). Further, in each channel (52, 53) is provided a non-return valve (50, 51 ) which permits fluid to flow only from the first end of the channel (52, 53) to its other end, and in the master cylinder's (1) cylinder part (2) are provided two drillings 12, 13) whose one end, when the piston is situated in a central or neutral position in the cylinder (2) leads into the cylinder wall at a point between the outer (54 or 55) and the inner (56 or 57) sealing rings, and whose other end communicates with a fluid reservoir.
Patent NO-911842-D0 (NO)
Inventor: WITT DONALD REINHOLD
IPC: C08F10/00
Filed: 1991-05-13
Abstract: An improved supported chromium oxide catalyst, a process for preparing the catalyst and a process for polymerizing olefin monomers utilizing the catalyst are provided. In accordance with the preparation process, chromium oxide and a support containing one or more of silica, titania, thoria, alumina, zirconia or aluminophosphates are combined, impregnated with a metal salt and activated. The metal salt is selected from the group consisting of alkali metal salts, alkaline earth metal salts and mixtures thereof.
Patent NO-921682-D0 (NO)
Inventor: BRONSTEIN IRENA
IPC: C07F9/12
Filed: 1992-04-29
Abstract: Enzymatically cleavable chemiluminescent 1,2-dioxetane compounds capable of producing light energy when decomposed, substantially stable at room temperature before a bond by which an enzymatically cleavable labile substituent thereof is intentionally cleaved, are disclosed. These compounds can be represented by formula (I) wherein X and X<1> each represent, individually, hydrogen, a hydroxyl group, a halo substituent, an unsubstituted lower alkyl group, a hydroxy (lower) alkyl group, a halo (lower) alkyl group, a phenyl group, a halophenyl group, an alkoxyphenyl group, a hydroxyalkoxy group, a cyano group, a carboxyl or substituted carboxyl group or an amide group, with at least one of X and X<1> being other than hydrogen; and R1 and R2 individually or together, represent an organic substituent that does not interfere with the production of light when the dioxetane compound is enzymatically cleaved and that satisfies the valence of the dioxetane compound's 4-carbon atom, with the provisos that if R1 and R2 represent individual substituents the R2 substituent is aromatic, heteroaromatic, or an unsaturated substituent in conjugation with an aromatic ring, and that at least one of R1 and R2 is, or R1 and R2 taken together are, an enzymatically cleavable labile group-substituted fluorescent chromophore group that produces a luminescent substance when the enzymatically cleavable labile substituent thereof is removed by an enzyme. The corresponding dioxetanes which, instead of being substituted at the 5' or 7', or at the 5' and 7' positions, instead contain a 4' methylene group, are also disclosed, as are intermediates for all these 3-substituted adamant-2'-ylidenedioxetanes, and their use as reporter molecules in assays.
Patent NO-930006-D0 (NO)
Inventor: KAASGARD SVEND GUNNAR
IPC: C12R1/19
Filed: 1993-01-04
Abstract: beta -Lactam derivatives are synthesized by an enzymatic reaction of the parent amino  beta -lactam with the corresponding acylating agent, the concentration of the acylating agent plus the concentration of  beta -lactam derivative in the reaction mixture being above about 400 mM.
Patent NO-941696-D0 (NO)
Inventor: VACCA JOSEPH P
IPC: C07D401/12
Filed: 1994-05-06
Abstract: Cpds. of formula (I) and their salts are new. In the formula X = OH or NH2; Z = O, S or NH; R = H or 1-4C alkyl; R1,R2 = e.g. H, 1-4C alkyl (opt. substd. by 1 or more from halo, OH, 1-3C alkoxy, aryl (opt. substd. by 1 or more from 1-4C alkyl, OH and aryl), -w-aryl, -w-benzyl, 5-7C cycloalkyl (opt. substd. by 1 or more from halo, OH, 1-3C alkoxy and aryl etc, or R1+N+R2 = eg. 3-10 member satd. monocyclic or bicyclic ring contg. 2-9C (opt. substd. by OH, 1-4C alkyl (opt. substd. by 1 or more from halo, OH, 1-3C alkoxy, aryl, 5-7C cycloalkyl (opt. substd. by 1 or more from halo, OH, 1-3C alkoxy and aryl), heterocycle and NR2) etc., or R1+N+R2 = eg. 3-10 member satd. monocyclic or bicyclic ring contg. 2-9C (opt. substd. by OH, 1-4C alkyl (opt. substd. by 1 or more from halo, OH, 1-3C alkoxy, aryl, 5-7C cycloalkyl (opt. substd. by 1 or more from halo, OH, 1-3C alkoxy and aryl), heterocycle and NR2) etc., or R1+N+R2 = 3-10 member satd. monocyclic or bicyclic ring contg. 1-8C and 1 or more additional heteroatom (opt. substd.), or R1+N+R2 = 3-10C member satd. monocyclic or bicyclic ring contg. 209C, fused to Ph (opt. substd. by 1 or more from halo, 1-3C alkoxy, OH, 1-4C alkyl, NHR, (where R1 is not joined to R2) and NH-heterocycle; R3 = (CH2)R4, 1-4C alkenyl-R4 or 1-4C alkynyl R4; R4 = eg. H, 1-4C alkyl, 5-10 cycloalkyl (opt. substd. by OH), 6-10C aryl (opt. substd. by 1 or more from halo, OH, NO2, NR2, 1-4C, 1-3C alkoxy (opt. substd. by 1 or more from OH and 1-3C alkoxy), CO2R, CONR2, CH2NR2, CH2NHCOR, CN, CF3, NHCOR etc, B = absent or -NH-CH(R8)-C(=Z)-; J1,J2 = -YR9, N(R9)2, NR10R11 or -Y(CR9R12)n-R12; W = O, S or NH; n = 0-3; R8 = CHMe2, CH(me)Et or Ph; Y = O or NH; R9 = eg. H, 1-6C alkyl (opt. substd. by 1 or more from NR2, OR, NHSO2 (1-4Calkyl), NHSO2 aryl, NHSO2 (dialkylaminoaryl) etc., R10+N+R11 = 5-7 member heterocycle opt. contg. 1 additional heteroatom O, S or NR); R12 = eg. H, aryl (opt. substd. by 1 or more from R14, -1-4C alkyl-NR2 and OCO(1-4Calkyl) etc.. R14 = halo, OR, CONR2, CH2NR2, SO2NR2, NR2, NHCOR, 1-4alkyl, Ph, CF3, N(R)SO2R, OP(O)(ORx)2 or CO2R.
Patent NO-954456-D0 (NO)
Inventor: GROOT JACOB F DE
IPC: C09K17/42
Filed: 1995-11-07
Abstract: The invention relates to a coherent growth substrate based on a synthetic matrix containing clay in a quantity of 0.1-25% by weight such that at a suction pressure of pF=2 the moisture content is lower than 15% by volume, preferably for use as a grow-block and for a grow-slab.
Patent NO-961995-D0 (NO)
Inventor: NILSSON BJORN
IPC: C07K14/65
Filed: 1996-05-15
Abstract: PCT No. PCT/SE94/01076 Sec. 371 Date Aug. 5, 1996 Sec. 102(e) Date Aug. 5, 1996 PCT Filed Nov. 14, 1994 PCT Pub. No. WO95/14034 PCT Pub. Date May 26, 1995Processes for refolding of insulin-like growth factor (IGF) comprise contacting IGF in a reduced or misfolded form with insulin-like growth factor binding protein (IGF-BP), and recovering native IGF.
Patent NO-965540-D0 (NO)
Inventor: MERRILL SONYA
IPC: A61K9/36
Filed: 1996-12-23
Abstract: A bilayer comprising a morphine layer of morphine, poly(alkylene oxide) and poly(vinylpyrrolidone); and an expandable contacting layer of coated granules of a higher molecular weight poly(alkylene oxide) and a hydroxyalkylcellulose, which bilayer is disclosed for morphine therapy. A method is disclosed for using the bilayer composition.
Patent NO-971104-D0 (NO)
Inventor: PROBA ZBIGNIEW
IPC: A61P7/04
Filed: 1997-03-11
Abstract: A process for the large-scale production of therapeutic grade thrombin of excellent viral safety and storage-stability is carried out by purification of viricide treated crude thrombin by ion-exchange chromatography on a single column using a sulfalkyl-activated polysaccharide, particularly a non-compressible composite medium of sulfoalkyl-activated dextran and silica particles, as the ion exchange medium and using increasing concentrations of phosphate buffer for elution. After recovery of thrombin in the final eluate, the phosphate buffer is exchanged for a stabilizing formulation buffer, and the stabilized thrombin is subjected to viral filtration and optional dry heat treatment for further viral inactivation. The final product has high specific activity and is obtained in good yield.
Patent NO-980903-D0 (NO)
Inventor: GEIGER KARL
IPC: A41C3/10
Filed: 1998-03-02
Abstract: A bra features textile reinforcing sections (13,14) in the lower and lateral sections of each cup (5,6). Each section (13,14) is connected with the associated strap (11,12) in the front top section. The straps (11,12) consist of a non-elastic material in the top front section at least and are in effective connection with the reinforcing parts (13,14) and with equally non-elastic parts (23,24) extending towards the top inner edges (21,22) of the cups (5,6).
Patent NO-982418-D0 (NO)
Inventor: DROPULIC BORO
IPC: G01N33/15
Filed: 1998-05-27
Abstract: The present invention provides a conditionally replicating viral vector, methods of making, modifying, propagating and selectively packaging, and using such a vector, isolatd molecules of specified nucleotide and amino acid sequences relevant to such vectors, a pharmaceutical composition and a host cell comprising such a vector, the use of such a host cell to screen drugs. The methods include the prophylactic and therapeutic treatment of viral infection, in particular HIV infection, and, thus, are also directed to viral vaccines and the treatment of cancer, in particular cancer of viral etiology. Other methods include the use of such conditionally replicating viral vectors in gene therapy and other applications. <IMAGE> <IMAGE> <IMAGE> <IMAGE> <IMAGE>
Patent GB-0104636-D0 (GB)
Title: Reduction of carbon dioxide emissions caused by buildings
IPC: F24F7/003
Filed: 2001-02-26
Abstract: A system for heating and ventilating a building comprising a heat pump consisting a compressor 9, at least one heat exchanger, a means for exhausting air from the building, at least one fan, a fresh air supply, a means for cooling the exhausted air and a controller. Preferably the system includes thermally insulated window shutters 21, 26. The heat pump construction may be contained with in an air tight casing 1, including an extractor fan 6 for removing the buildings internal circulating air via a spigot 2, and then passing this circulating air over an evaporator 8 to cool the air below that of the external air, before exhausting it to the external atmosphere via a spigot 4. The refrigerant vapour produced from the evaporator 8 is pumped by the compressor to a first condenser 10 used primarily for warming the incoming fresh air, induced by a fan 11 via a spigot 5. The external fresh air is preferably cleaned via a filter 12 and optionally dehumidified by a second evaporator 13 before being reheated by the first condenser and finally distributed into the building via spigots 3. Furthermore, a reversing valve may be used to change the function of the condenser 10 so that it becomes an evaporator, cooling the fresh air supply, and the evaporator coil 8 acts as a condenser to dissipate the heat extracted by the condenser 10. Periodically the refrigerant fluid flow through the evaporator 8 may be reversed so that it is continually defrosted. An additional condenser 14 may be included for heating tap water or a fluid for the purpose of transferring heat to a heat store. Alternatively, the cooled exhausted air may be used to cool a food storage area.
Patent GB-0125176-D0 (GB)
Title: A method of compiling bytecode to native code
IPC: G06F9/45
Filed: 2001-10-19
Abstract: A method of compiling byte code into native code disclosed together with a server ( 100 ) and a receiving terminal ( 101 ) for the same. The method comprises the steps of transmitting byte code files containing byte code from a server to a receiving terminal; transmitting grouping information relating to the grouping of byte code files to the receiving terminal; and compiling byte code files received at the receiving terminal to native code. The byte code files are selected for compilation as a function of the grouping of byte code files.
Patent GB-0129098-D0 (GB)
Title: Method and arrangement for power control
IPC: H04B7/005
Filed: 2001-12-05
Abstract: A method for selecting a transport format to transmit messages in a wireless communication system is provided. The method comprises: obtaining status information from a wireless subscriber unit; and modifying a communication channel format in response to said status information.
Patent GB-0214098-D0 (GB)
Title: Processor system wake-up
IPC: H04M1/73
Filed: 2002-06-19
Abstract: A method of waking up components in a dual-processor based system. The system includes a first processor system to be activated. Upon activation, components in a second processor based system are required to be likewise activated. The method comprises initiating a wake-up process of a first processor system, waking-up the first processor system components, and generating an interrupt signal. The interrupt signal is passed to the second processor system to initiate a wake-up process of the second processor system components that are required to be woken for the wake-up process of the first processor system. This is performed such that the second processor system components are activated at, or before, a time when the first processor system requires second processor system components to be activated. A dual processor based system is also described. In this manner, components used in a second processor system, for example a man machine processor system, are awoken in a timely manner when they are needed in the awakening process of the first processor system, for example a GSM processor system to facilitate the periodic scanning of a GSM control channel or timeslots. This prevents delay and reduces power consumption.
Patent GB-0221892-D0 (GB)
Title: Process
IPC: C09D11/10
Filed: 2002-09-20
Abstract: A process for making an electronic device comprising a dielectric substrate laminated with an electrically conductive metal or alloy which comprises applying a non-aqueous etch-resistant ink by ink jet printing to selected areas of the metal or alloy, exposing the etch-resistant ink to actinic radiation and/or particle beam radiation to effect polymerisation, removing exposed metal or alloy by a chemical etching process and then removing the polymerised etch-resistant ink by alkali wherein the etch-resistant ink is substantially solvent free and comprises the components: A) 30 to 90 parts acrylate functional monomers free from acid groups comprising mono or higher functionality wherein 5-95% by weight is one or more mono-functional monomers; B) 1 to 30 parts acrylate functional monomer containing one or more acid groups; C) 0 to 20 parts polymer or prepolymer; D) 0 to 20 parts radical initiator; E) 0 to 5 parts colorant; F) 0 to 5 parts surfactant; and wherein the ink has a viscosity of not greater than 30 cPs (mPa.s) at 40° C. and all parts are by weight.
Patent GB-0312092-D0 (GB)
Title: Low spring rate multi-convoluted collapsible spacer
IPC: F16C35/06
Filed: 2003-05-27
Abstract: A low spring rate multi-convoluted collapsible spacer adapted for use as a bearing preloading element. The collapsible spacer comprises a substantially tubular body compressible in an axial direction thereof from a predetermined free length to a substantially shorter length. The tubular body includes a yielding zone and an elastic zone adjacent to said yielding zone. Each of the yielding and elastic zones has at least one convolution curved in the same radial direction. An average thickness of the body of the spacer in the elastic zone is substantially greater than an average thickness of the body in the yielding zone that provides the collapsible spacer a substantially higher resiliency in the axial direction in the elastic zone than in the yielding zone. As a whole, the collapsible spacer has a relatively low spring rate, thus larger amount of "spring back", hence less sensitivity to wear and maladjustment.
Patent GB-0314368-D0 (GB)
Title: Composition, use and process
IPC: C09D11/00
Filed: 2003-06-20
Abstract: A metal chelate compound of Formula (1) or a salt thereof: <?in-line-formulae description="In-line Formulae" end="lead"?>[A-N-N-B]M Formula (1)<?in-line-formulae description="In-line Formulae" end="tail"?> wherein: A is an optionally substituted pyridyl ring; and B is of the Formula (2): wherein: X and W are substituents other than H; M is a metal chelated to A-N-N-B; and n is 0 to 4, also claimed are compositions and inks containing a compound of Formula (1), a process for ink jet printing using the inks and an ink jet printer cartridge containing the ink.
Patent GB-0323218-D0 (GB)
Title: Method and apparatus for distributed administration of thin client architecture
IPC: G06Q10/00
Filed: 2002-03-19
Abstract: The present invention provides a method and apparatus for distributed administration of thin client architecture. In one embodiment of the present invention, administrative tasks are accomplished by multiple administrators. In one embodiment, the number of administrative tasks assigned to an administrator is approximately uniform throughout the computer system. In this embodiment, creation of multiple user accounts is accomplished by assigning each administrator a roughly equal number of user accounts to create. Workgroup administration is accomplished similarly. In one embodiment, students are users and teachers are administrators.
Patent GB-0413524-D0 (GB)
Title: Safety seringe with re-usable main parts, method for disposable of a needle into a container and container for disposable parts
IPC: A61M5/32
Filed: 2002-11-29
Abstract: A syringe has a barrel to receive a cartridge. The barrel has a front end portion to which a needle is connected for engagement with the cartridge. At its rear end, the barrel has a plunger mechanism. A sleeve is slidably mounted on the barrel and can be pushed forwards to sheath the needle. The needle is mounted on the barrel via a push-fit mounting device. The needle can be removed for disposal in a container by inserting the syringe into a tube on top of the container so that the protective needle sleeve is pushed back and the needle and mounting device pass through a collar of gripping fingers at an inner end of the tube. The fingers catch behind the mounting device so that this is pulled off to drop into the container with the needle when the syringe is withdrawn from the tube.
Patent GB-0426523-D0 (GB)
Title: Video processing
IPC: G06K9/00
Filed: 2004-12-02
Abstract: Video data comprising a plurality of sets of frame data is captured by mobile video data capture device. The video data is processed by a method which comprises: (a) finding a face in each frame of the video, and (b) processing a corresponding set of frame data to: (i) maintain the area of the image occupied by the face substantially constant; and (ii) maintain the apparent direction of light incident upon the face substantially constant; and/or (iii) maintain the apparent color of the face substantially constant.
Patent GB-0525492-D0 (GB)
Title: Filaggrin
Filed: 2005-12-15
Abstract: The present invention relates to the identification of loss-of-function mutations in the filaggrin gene and their use in diagnosing ichthyosis vulgaris and/or susceptibility to other diseases including atopic dermatitis (eczema), asthma, psoriasis and allergies (including food allergy).
Patent GB-0526562-D0 (GB)
Title: Magazine and tab for a fastening device
IPC: B25C5/00
Filed: 2003-01-10
Abstract: A fastening system that enables a tab to be positioned around items to be joined, and a fastener to be passed through the tab and the items to be joined to fasten these. The invention relates to a fastening device for effecting the system, a magazine for storing and dispensing tabs and to the tabs.
Patent GB-0620177-D0 (GB)
Title: A freezer to retarder to oven dough
IPC: A21D2/00
Filed: 2005-03-11
Abstract: A frozen dough comprising flour, a high yeast level comprising one or more yeast with activity covering temperature range of 33-140° F., emulsifiers, dough conditioners, stabilizers, sugar, lipid source and optionally supplemental gluten such that the frozen dough does not require a conventional proofing (proofer) step prior to freezing or prior to baking. When the frozen dough is thawed in a retarder at 33-42° F. for at least 12 hours, or at an elevated temperature of between 43-85° F. for at least 1 hour, and then baked, the baked products have good appearance, taste and texture, and a specific volume of at least 4 cc/gram.
Patent GB-8430361-D0 (GB)
Title: Syphon assembly
IPC: E03D1/06
Filed: 1984-11-30
Abstract: Siphon assembly for a flushing cistern is in two parts (10, 11); the first including the down leg of the siphon duct the lower end of which is mounted in the cistern base and the second including the up leg and the inlet chamber (20) in which the flushing piston is received. The parts are releasably connected by a push fit spigot and socket joint (12, 17) secured by a removable pin (27) received transversely through locating formations (25. 26) on each part near the tops of the legs, further formations (30, 31) near the bottoms of the legs being received in vertical sliding relationship.
Patent GB-8500039-D0 (GB)
Title: Compound
IPC: C12N1/20
Filed: 1985-01-02
Abstract: 57 The invention relates to a new compound, designated FR-68504. The compound has antitumor activities and is effective in the treatment of various tumors in both human beings and animals.There is also provided a process for preparing FR-68504 compound which comprises culturing a FR-68504 producing strain belonging to the genus Amauroascus in a nutrient medium.Pharmaceutical composition comprising FR-68504 as an active ingredient is also described.f) UV absorption spectrum :End absorption (in H<sub>2</sub>0)g) IR absorption spectrum :Nujol: 3400, 3250, 1300, 1100, 1030, 950, max 850 cm-1h) <sup>1</sup>H NMR absorption spectrum : (D<sub>2</sub>0) δppm: 3.94-3.78 (4H, m), 3.57 (lH, dd, J=9.2 and 5.3Hz), 3.36-3.25 (2H, m), 3.01-2.88 (4H, m)i) 13<sub>C NMR</sub> absorption spectrum : (D<sub>2</sub>0) δppm: 71.0 (d), 70.6 (d), 70.4 (d), 69.6 (d), 68.6 (d) , 55.1 (d), 53.5 (d) , 46.6 (t), 46.5 (t)j) Solubility :Soluble : WaterSparingly soluble : Methanol, ethanol, acetoneInsoluble : Ethyl acetate, chloroformk) Color reaction :Positive : Molish's reaction, reaction with cerium sulfateNegative : Ninhydrin reaction, ferric chloride-potassium ferricyanide reaction, reaction with Dragendorff reagent or iodine vapor.1) Property of substance :Neutral substancem) Thin layer chromatography (silica gel sheet) :The FR-68504 can be prepared by culturing a FR-68504-producing strain belonging to the genus